Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Exopharm Limited (AU: EX1)

 
EX1 Technical Analysis
5
As on 11th Jul 2023 EX1 STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.19 & Strong Sell for SHORT-TERM with Stoploss of 0.33 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

EX1STOCK Price

Open 0.01 Change Price %
High 0.01 1 Day 0.00 0.00
Low 0.01 1 Week 0.00 0.00
Close 0.01 1 Month 0.00 0.00
Volume 4478032 1 Year -0.43 -97.73
52 Week High 0.48 | 52 Week Low 0.01
 
AU Australia Most Active Stocks
MOB 0.02 100.00%
SI6 0.01 %
GMN 0.01 0.00%
LPD 0.01 0.00%
LDX 0.06 -14.29%
S32 3.69 3.65%
WWI 0.02 100.00%
HWK 0.09 %
SYA 0.19 5.56%
G88 0.05 -16.67%
 
AU Australia Top Gainers Stocks
CLB 1.10 2100.00%
CLB 1.10 2100.00%
CLB 1.10 2100.00%
APV 0.02 100.00%
CDT 0.02 100.00%
CDT 0.02 100.00%
EMP 0.02 100.00%
EMP 0.02 100.00%
EMP 0.02 100.00%
MOB 0.02 100.00%
 
AU Australia Top Losers Stocks
VMS 0.01 -50.00%
VMS 0.01 -50.00%
VAR 0.01 -50.00%
VAR 0.01 -50.00%
VAR 0.01 -50.00%
FFG 0.01 -50.00%
HT8 0.01 -50.00%
AQD 0.01 -50.00%
MCL 0.05 -37.50%
MCL 0.05 -37.50%
 
 
EX1
Daily Charts		 EX1
Intraday Charts		 Whats New @
Bazaartrend		 EX1
Free Analysis
 
EX1 Important Levels Intraday
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
RESISTANCE0.01
 
EX1 Forecast May 2024
Share
4th UP Forecast0.36
3rd UP Forecast0.25
2nd UP Forecast0.18
1st UP Forecast0.11
1st DOWN Forecast-0.09
2nd DOWN Forecast-0.16
3rd DOWN Forecast-0.23
4th DOWN Forecast-0.34
 
EX1 Weekly Forecast
4th UP Forecast0.20
3rd UP Forecast0.14
2nd UP Forecast0.10
1st UP Forecast0.06
1st DOWN Forecast-0.04
2nd DOWN Forecast-0.08
3rd DOWN Forecast-0.12
4th DOWN Forecast-0.18
 
EX1 Forecast2024
4th UP Forecast0.92
3rd UP Forecast0.63
2nd UP Forecast0.45
1st UP Forecast0.27
1st DOWN Forecast-0.25
2nd DOWN Forecast-0.43
3rd DOWN Forecast-0.61
4th DOWN Forecast-0.9
 
 
EX1 Other Details
Segment EQ
Market Capital 78606000.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
EX1 Address
EX1
 
EX1 Latest News
 
Your Comments and Response on Exopharm Limited
 
EX1 Business Profile
Exopharm Limited, a clinical-stage company, develops transformative medicines based upon extracellular vesicles (EVs) in Australia. The company's technology includes extracellular vesicle positioning system that allows specific molecules to be attached to the surface of exosomes to guide them to target tissues or cell types; leveraging oligonucleotide packing for amplified dosing, which enables specific RNA molecules to be preferentially loaded into exosomes as a therapeutic cargo; ligand-based exosome affinity purification that isolates and purifies exosomes from biofluids like blood and cell culture media. Its engineered EVs products comprise Fortrexo CoV for the treatment of SARS-CoV-2 infection; Cognevo for the treatment of neuro degeneration; and PlexoDox for the treatment of cancer. Exopharm Limited has a research collaboration with Showa Denko Materials Co., Ltd. The company was incorporated in 2013 and is based in Melbourne, Australia. Address: 31 Queen Street, Melbourne, VIC, Australia, 3000
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service